$1.3 M

Biosynergy Revenue FY, 2019
Biosynergy Gross profit (FY, 2019)868.9 K
Biosynergy Gross profit margin (FY, 2019), %67.3%
Biosynergy Net income (FY, 2019)73.5 K
Biosynergy EBIT (FY, 2019)100.3 K
Biosynergy Cash, 30-Apr-20191.2 M

Biosynergy Revenue

Biosynergy revenue was $1.29 m in FY, 2019

Embed Graph

Biosynergy Funding

Summary Metrics

Founding Date

1976

Biosynergy Income Statement

Annual

USDFY, 2016FY, 2017FY, 2019

Revenue

1.3m1.3m1.3m

Cost of goods sold

414.8k376.3k422.7k

Gross profit

923.2k916.3k868.9k

Gross profit Margin, %

69%71%67%

Sales and marketing expense

199.2k190.5k189.2k

R&D expense

157.4k160.9k160.4k

General and administrative expense

421.4k416.3k419.0k

Operating expense total

778.0k767.7k768.5k

EBIT

145.2k148.6k100.3k

EBIT margin, %

11%11%8%

Interest income

411.0407.0534.0

Income tax expense

41.2k43.7k29.3k

Net Income

106.3k107.2k73.5k

Biosynergy Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2019

Cash

1.1m1.0m1.2m

Accounts Receivable

267.5k246.4k

Prepaid Expenses

32.2k57.7k

Inventories

109.0k26.8k17.3k

Current Assets

1.4m1.5m1.6m

PP&E

19.9k12.3k

Total Assets

1.7m1.9m

Accounts Payable

4.6k3.8k4.5k

Current Liabilities

69.2k71.7k156.3k

Common Stock

20.0m20.0m

Retained Earnings

837.2k944.4k1.1m

Total Equity

1.6m1.7m

Financial Leverage

1.1 x1.1 x

Biosynergy Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2019

Net Income

106.3k107.2k73.5k

Depreciation and Amortization

16.7k17.8k22.1k

Accounts Receivable

(29.1k)(75.5k)(15.7k)

Inventories

47.0k(83.6k)(23.4k)

Accounts Payable

(7.1k)2.5k(4.5k)

Cash From Operating Activities

133.8k(28.9k)50.7k

Purchases of PP&E

(1.1k)(13.6k)(11.0k)

Cash From Investing Activities

(18.0k)(22.2k)(11.0k)

Net Change in Cash

115.9k(51.1k)39.7k

Income Taxes Paid

37.8k46.4k37.0k

Biosynergy Ratios

USDQ1, 2012

Financial Leverage

1.1 x